Impact of Rosuvastatin Treatment on HDL-Induced PKC-βII and eNOS Phosphorylation in Endothelial Cells and Its Relation to Flow-Mediated Dilatation in Patients with Chronic Heart Failure

Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin TherapyCLINICAL PERSPECTIVE

(2016) Ian Ford et al.   CIRCULATION

Proteome profiles of HDL particles of patients with chronic heart failure are associated with immune response and also include bacteria proteins

(2016) Andreas Oberbach et al.   CLINICA CHIMICA ACTA

Induction of Scavenger Receptor Class B Type I Is Critical for Simvastatin Enhancement of High-Density Lipoprotein-Induced Anti-Inflammatory Actions in Endothelial Cells

(2014) T. Kimura et al.   JOURNAL OF IMMUNOLOGY

High density lipoprotein from patients with valvular heart disease uncouples endothelial nitric oxide synthase

(2014) Feng-Jun Chang et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Effect of atorvastatin on paraoxonase1 (PON1) and oxidative status

(2014) Amar Nagila et al.   Pharmacological Reports

Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients

(2014) D. Keene et al.   BMJ-British Medical Journal

Exercise training improves high-density lipoprotein-mediated transcription of proangiogenic microRNA in endothelial cells

(2014) Saskia Riedel et al.   European Journal of Preventive Cardiology

High-Density Lipoprotein

(2013) Ali Javaheri et al.   CIRCULATION RESEARCH

Exercise Training in Patients with Chronic Heart Failure Promotes Restoration of High-Density Lipoprotein Functional Properties

(2013) Volker Adams et al.   CIRCULATION RESEARCH

Correlation between endothelial function measured by finger plethysmography in children and HDL-mediated eNOS activation — a preliminary study

(2013) Ulrike Müller et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Cross-talk Between Exogenous Statins and Endogenous High-Density Lipoprotein in Anti-Inflammatory and Anti-Atherogenic Actions

(2012) Takao Kimura et al.   Endocrine Metabolic & Immune Disorders-Drug Targets

A new look at HDL in coronary disease: can we escape natural history?

(2011) S. Gielen et al.   HEART

Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

(2011) Christian Besler et al.   JOURNAL OF CLINICAL INVESTIGATION

Statin Rebound or Withdrawal Syndrome: Does It Exist?

(2010) Andres Pineda et al.   Current Atherosclerosis Reports

High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling — Results from a randomized, double-blind, and placebo-controlled study

(2010) Sandra Erbs et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Endothelial function in subjects with isolated low HDL cholesterol: role of nitric oxide and circulating progenitor cells

(2009) Yukihito Higashi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Fluvastatin Treatment and Withdrawal: Effects on Endothelial Function

(2008) Sabine Westphal et al.   ANGIOLOGY

Effects of exercise training upon endothelial function in patients with cardiovascular disease

(2007) Axel Linke   Frontiers in Bioscience-Landmark